In conclusion, our results suggest that sequential NIPPV + IMT treatment alleviated dyspnea and improved exercise tolerance and quality of life in COPD patients, which might be related to reduced levels of oxidative stress mediated by SOCS5/JAK2/STAT3 signaling pathway. Here, SOCS5 is linked to chronic obstructive pulmonary disease.